American Oriental Bioengineering (American Oriental Bioengineering) EV-to-EBIT : 0.00 (As of Jun. 25, 2024)

American Oriental Bioengineering EV-to-EBIT Chart

American Oriental Bioengineering Annual Data
	Trend	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
EV-to-EBIT		Get a 7-Day Free Trial					9.50	7.01	7.30	-2.51	-2.24

American Oriental Bioengineering Quarterly Data
	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13
EV-to-EBIT	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of American Oriental Bioengineering's EV-to-EBIT

For the Biotechnology subindustry, American Oriental Bioengineering's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

American Oriental Bioengineering's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, American Oriental Bioengineering's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where American Oriental Bioengineering's EV-to-EBIT falls into.

American Oriental Bioengineering EV-to-EBIT Calculation

American Oriental Bioengineering's EV-to-EBIT for today is calculated as:

American Oriental Bioengineering's current Enterprise Value is $0.0 Mil.
American Oriental Bioengineering's EBIT for the trailing twelve months (TTM) ended in Sep. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oriental Bioengineering  (OTCPK:AOBI) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

American Oriental Bioengineering's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2013 is calculated as:

American Oriental Bioengineering's Enterprise Value for the quarter that ended in Sep. 2013 was $106.0 Mil.
American Oriental Bioengineering's EBIT for the trailing twelve months (TTM) ended in Sep. 2013 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oriental Bioengineering EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of American Oriental Bioengineering's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

American Oriental Bioengineering (American Oriental Bioengineering) Business Description